Mifepristone (MIF) and Tamoxifen (TAM) have been used in the treatment of prostate cancer and breast cancer for more than a decade. MIF can induce apoptosis in both AR-positive and -negative prostate cancer cells. Because of its pleiotropic ligand-receptor properties, TAM exerts cytotoxic activity in estrogen (ER)-positive and various ER-negative cancer cells. However, the molecular mechanisms of these two substances are not yet clear. In the present work, we report that the cytotoxic effects of MIF and TAM are due to the modulation of intracellular Ca 2+ level in DU-145, androgen-insensitive cells. When the cells were treated with micromolar concentrations of either MIF or TAM, the growth and viability were significantly decreased in a dose-and time-dependent manner. The apoptosis induced by MIF or TAM was further proved and analyzed by confocal laser scanning microscopy (CLSM) and fluorescence-activated cell sorting (FACS). In the cells cultivated in a normal 1.5 mM Ca 2+ medium, both MIF and TAM also induced an increase of the intracellular Ca 2+ level in a dose-dependent fashion. Since a change in calcium level could not be found in cells of the Ca 2+ -free medium, the increase of intracellular Ca 2+ level might be due to an increase in extracellular calcium uptake. Our results show that the apoptotic effect was more prominent in TAM treatment compared to MIF treatment in DU-145 cells. The above findings might be due to the difference in the uppermost pathways of apoptosis induced by either MIF or TAM. When we checked the level of procaspase-8 activation, TAM showed minor level of activation, as opposed to MIF, which exerted strong activation. In both treatments, the levels of anti-apoptotic protein Bcl-2 decreased, and pro-apoptotic protein Bax level increased more than 2-fold. The activation of caspase-3, a key protease enzyme in the downstream pathway of apoptosis, was much higher in the cells treated with TAM, compared to the MIF treatment. The overall apoptotic activity shown in the present work was closely related to intracellular Ca 2+ concentration levels. Therefore, the cytotoxic activity induced by MIF and TAM might have been due to intracellular calcium modulation.
Introduction
Prostate cancer is the most common cancer in men of the western world. In the USA, it is the second leading cause of cancer-related death in men. Recently, the number of cases diagnosed with prostate cancer is rapidly on the increase in Korea. Steroid hormones, especially androgens, play critical roles in the development and growth of the male reproductive system. Their functions are mediated by the androgen receptor (AR). MIF is a progesterone analogue and is known as a potent progesterone antagonist. MIF is also used as a selective androgen receptor (SAR) modulator because this compound interacts with AR and its corepressors [2, 19] . Because of this strong AR antagonistic activity, MIF has been used in the treatment of prostate cancer. Although MIF has been known to inhibit prostate cancer cell growth in vitro and in vivo, its molecular mechanisms are not yet clear [2, 6, 20] . MIF can induce apoptosis in androgen-sensitive (LNCaP) and androgen-insensitive (PC-3, DU-145) cell lines [22] . These findings suggest that the apoptotic characteristics induced by MIF are not just androgen antagonistic activities. Even though the precise role of MIF in apoptosis appears to be complex and not clear, it has been known that mitochondria play key roles in the apoptotic process through the activation of caspases [10, 14, 18] .
TAM has been used in the treatment of breast cancer for more than three decades; however, the precise molecular mechanisms underlying TAM-induced cytotoxicity are as of yet unclear. Recent reports have shown that TAM inhibits the proliferation and induces apoptosis not only in estrogen receptor (ER)-positive breast cancer cells, but also in ER-neg-ative breast cancer cells and other cancer cells; i.e., prostate cancer, ovarian cancer, colorectal cancer, and brain cancer [1, 13, 17] . Non-genomic effects of TAM has been suggested in many cell lines; including the inhibition of protein kinase C [3] , interferences with the function of ion channels [7] , and the activation of extracellular signal-regulated kinase (ERK1/2) [23] . Recently, it has also been reported that TAM induces apoptosis by the initiation of a mitochondrial death program [8] . TAM-induced cytotoxicity has been associated with release of mitochondrial cytochrome c, a decrease of mitochondrial membrane potential, an increase in production of reactive oxygen species, and stimulation of mitochondrial NO synthase.
Apoptosis is physiological cell death regulated by genetic mechanisms and is principally characterized by morphological and biochemical changes in their nuclei, including chromatin condensation and internucleosomal DNA fragmentation. Caspases, a family of cysteine protease, play a central role in the signaling and execution of apoptosis [21] . , inducing a change in the mitochondrial membrane potential. The collapse of the membrane potential results in the release of cytochrome c and other apoptosis-inducing factors from mitochondria, which is followed by the activation of caspase, nuclear fragmentation, and cell death.
In recent years, a great deal of attention has been placed on the possible correlation between the effects of members of the Bcl-2 family of proteins on Ca 2+ homeostasis and their role in the control of apoptosis [5] . Bcl-2 is the first family member proposed to have the ability to alter intracellular Ca 2+ homeostasis. Anti-apoptotic members in the Bcl-2 family, such as Bcl-2 and Bcl-XL, are preferentially localized in the mitochondrial membrane and protect mitochondria from perturbation, thereby preventing cell death [9] . The specific localization of Bcl-2 in the membranes of mitochondria and ER, and the demonstration that Bcl-2 acts as an ion channel when inserted into lipid bilayers suggest that Ca 2+ signaling could be a target of the action of this anti-apoptotic oncoprotein [15] . Therefore, in the present work, the effects of MIF and TAM on intracellular calcium level change, cell viability, and Bcl-2 family protein expressions were investigated to see if intracellular calcium modulation leads to apoptotic death in DU-145 human prostate cancer cells.
Materials and Methods
Chemicals and cell culture heat-inactivation FBS in a humidified atmosphere of 95% air; 5% CO2 at 37 o C. Culture media were changed every 2 or 3 days. Cells were harvested using trypsin-EDTA and subcultured at weekly intervals. for 30min.
Measurement of cell viability

Assessment of morphology
Nuclear condensation and/or chromatin fragmentation found during early apoptosis was determined morphologically by CLSM (LSM510, Carl Zeiss, Oberkohen, Germany) after labeling PI and Hoechst dye. Cells with each treatment were harvested onto a clean, fat-free glass slide with cellspin (Hanil Sci. Industrial, Korea). The cells were then fixed for 30 min in 4% paraformaldehyde and then stained in 4 μg/ml Hoechst 33342 or 10 μg/ml PI with 50 μg/ml ribonuclease A for 1 hr at 37°C. The cells were observed and photographed by CLSM (LSM510).
Cell cycle analysis Cells were harvested, fixed with 95% ethanol for 24 hr, incubated with 0.05 mg/ml PI and 1 μg/ml RNAse A at 37 o C for 30 min, and analyzed by flowcytometry, using and Epics XL and analysis software (EXPO32TM; Beckman Coulter, MI, USA). The cells belonging to the sub-G1 population were considered to be apoptotic cells; the percentage of each phase of the cell cycle was determined.
Western blot analysis
Cells were collected by centrifugation at 5,000 rpm for 10 min at 4°C. Proteins were extracted by washing cells twice with ice-cold PBS and incubating them for 60 min on ice in lysis buffer containing 50 mM Tris-HCl (pH 7.6), 300 mM NaCl, 0.5% Triton X-100, 2 mM phenylmethylsulfonyl fluoride, 2 μg/ml aprotinin, and 2 μg/ml leupeptin. For Western blotting, an aliquot of 60 μg of protein was separated by sodium dodecylsulfate-polyacrylamid gel electrophoresis (SDS-PAGE) and then transferred to a nitrocellulose transfer membrane. Blotting was performed using the primary antibodies of anti-Bcl-2, anti-Bax, anti-procaspase-8, anti-cleaved caspase-3, and then with the proper secondary antibody (Sigma, MO, USA). The immuncomplexes were detected by using the enhanced chemiluminescence (ECL) detection kit (Amersham Pharmacia Biotech Korea, Inc., Seoul, Korea).
Statistical analysis
All experiments were carried out at least in triplicate.
Results were expressed as mean ± SEM. Statistical significances between the control and the treatment group were determined by one-way analysis of variance and then followed by the Student T test. In all cases, a p value of less than 0.05 was considered statistically significant.
Results
Effects of MIF and TAM on cell viability of the ongoing experiments were performed at a concentration of less than 40 μM MIF.
Cells treated with 20 μM MIF showed 82%, 63%, and 34% of viability on 2, 3, and 4 days incubation, respectively, compared to the control.
In the cells treated with TAM, viability was also decreased in a dose-and time-dependent fashion (Fig. 1B) . The cytotoxic effect of TAM was stronger than that of MIF in DU-145.
Even at 10 μM, cell viability was decreased severely.
Therefore, most of the ongoing experiments were performed at a concentration less than 20 μM TAM. However, at a concentration less than 5 μM, TAM slightly induced cell proliferation. Cells treated with 20 μM TAM showed 67%, 24%, and 17% viability at 2, 3, and 4 days of incubation, compared to the control.
Assessment of cell morphology
MIF has been known to induce apoptosis in prostate cancer cells. To examine this in the present experiment, we studied the morphological change in the nuclei of the cells treated by staining with Hoechst and PI dye. The cells were treated with either MIF or TAM, and the morphological change of nuclei was observed by a laser confocal scanning microscope after dye treatments. As shown in Fig. 2 , the cells treated with 20 μM MIF for 2 days already showed the characteristic nuclei condensation and shrinkage, which was a typical TAM has been also known to induce apoptosis in many ER-positive and ER-negative cancer cells. In DU-145 cells treated with 10 or 20 μM TAM, severe chromatin condensation and nuclear fragmentation within 2 days of treatment, which was a typical early event of apoptotic cell death, could clearly be found (Fig. 3) .
Detection and quantification of apoptosis
To detect and quantify apoptosis, cells were incubated with MIF and TAM at concentrations of 10 μM and 20 μM, respectively, for 2 days. The results were analyzed by flow cytometer, and the cell population belonging to sub-G1 was considered to be an apoptotic group. As shown in Fig.   4 , the cytotoxic effect of TAM was much higher than that of MIF at the same concentrations. Cells treated with 20 μ M MIF showed 9.36% apoptosis of total cells. However, cells treated with TAM at the same concentration induced 25.31% apoptosis within 2 days of treatment, which could be a considerable apoptotic percentage compared with the control. 
Effects of MIF and TAM on caspase activation
and Bcl family protein expression There are two distinct molecular signaling pathways that lead to apoptotic cell death; mitochondria-mediated pathway and receptor-mediated pathway [4] . Procaspase-8 is cleaved and activated in the early stage of the receptor-mediated pathway. Caspase-3 can be activated in both pathways. The Bcl-2 family proteins are very important in mitochondria-mediated pathways, but the two pathways can also be linked to each other. Therefore, the changes in level of expression of the above proteins were analyzed by Western blotting (Fig. 7) . The level of procaspase-8 expression was severely reduced, thus as a result of its cleavage and activation by the 20 μM MIF treatment for 2 days. However, the activation of procaspase-8 was not as prominent in the cells treated for 2 days with 20 μM TAM. Activation of caspase-3 showed the opposite results compared to procaspase-8. With MIF treatment, caspase-3 was activated to 164% of the control, but activated to 267% in TAM treatment. The level of Bcl-2 expression, an anti-apoptotic protein, decreased noticeably in both treatments. To the contrary, expression of Bax, a pro-apoptotic protein, increased dramatically in both the MIF and TAM treatments. 
